[1] Shi M, Chu F, Jin T, Zhu J. Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD):novel insights into therapeutic possibilities in NMOSD[J]. CNS Neurosci Ther, 2022, 28:981-991. [2] Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy:a review of the literature[J]. Front Immunol, 2018, 9:2802. [3] Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, Lopez-Chiriboga AS, Pittock SJ, Flanagan EP. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD):a review of clinical and MRI features, diagnosis, and management[J]. Front Neurol, 2022, 13:885218. [4] Expert Committee of J. EDU Medical Cell Platform Soliciting Contributions. Consensus of Chinese experts on cellular morphological examination of cerebrospinal fluid (2023)[J]. Xian Dai Jian Yan Yi Xue Za Zhi, 2023, 38:1-5.[君安医学细胞平台专家委员会.脑脊液细胞形态学检验中国专家共识(2023)[J].现代检验医学杂志, 2023, 38:1-5.] [5] Wang N, Zhang SN, Xing RJ, Liu MQ, Huang CN, Jiang SM, Li T, Yang CS, Yang L, Zhang LJ. Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders:a hint on differential diagnosis and possible immunopathogenesis[J]. Mult Scler Relat Disord, 2021, 47:102629. Mao Z, Qiu W, Hu X, Wingerchuk DM, [6] Tan CT, Weinshenker BG. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology, 2016, 86:491-492. JL, Marignier R, Kim HJ, Brilot F, [7] Banwell B, Bennett Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock SJ, Fujihara K, Palace J. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease:International MOGAD Panel proposed criteria[J]. Lancet Neurol, 2023, 22:268-282. progress of autoimmune glial [8] Wang WW, Li M. Research fibrillary acidic protein astrocytopathy[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2022, 22:205-210.[王文雯,李梅.自身免疫性胶质纤维酸性蛋白星形胶质细胞病研究进展[J].中国现代神经疾病杂志, 2022, 22:205-210.] [9] Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease[J]. Nat Rev Neurol, 2019, 15:89-102. [10] Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy:analysis of 102 patients[J]. Ann Neurol, 2017, 81:298-309. [11] Chen JH, Zhang XP, Xu M, He PP, Yan HL, Wang XB. Association of AQP-4 and MOG antibody expression with clinical manifestations, cerebrospinal fluid biochemical characteristics and prognosis in patients with neuromyelitis optica spectrum disorders[J]. Yi Nan Bing Za Zhi, 2022, 21:815-821.[陈剑华,张雪萍,徐杪,何盼盼,闫鹤立,王向波.视神经脊髓炎谱系疾病患者AQP-4、MOG抗体表达与临床表现、脑脊液生化特征及预后的关系[J].疑难病杂志, 2022, 21:815-821.] [12] Wang LJ, Ou Z, Wei M, Yang X, Huang Y, Zhai ZY, Xu FG, Tong Q, Zheng JL, Xue LJ. Autoimmune glial fibrillary acidic protein astrocytopathy:two cases report[J]. Zhongguo Shen Jing Mian Yi Xue He Shen Jing Bing Xue Za Zhi, 2022, 29:332-334.[王丽君,欧洲,魏明,杨秀,黄悦,翟志远,许富贵,佟强,郑金龙,薛刘军.自身免疫性胶质纤维酸性蛋白星形细胞病两例[J].中国神经免疫学和神经病学杂志, 2022, 29:332-334.] [13] Schizodimos T, Soulountsi V, Iasonidou C, Kapravelos N. An overview of management of intracranial hypertension in the intensive care unit[J]. J Anesth, 2020, 34:741-757. [14] Wang XL, Li B, Liu J, Zhou Y, Wei SX, Zhen N. Clinical analysis of 328 cases of Guillain-Barrés syndrome with high cranial pressure[J]. Nao Yu Shen Jing Ji Bing Za Zhi, 2021, 29:89-93.[王雪笠,李波,刘军,周毅,魏士贤,甄宁.吉兰-巴雷综合征伴高颅压328例临床分析[J].脑与神经疾病杂志, 2021, 29:89-93.] [15] Fadda G, Flanagan EP, Cacciaguerra L, Jitprapaikulsan J, Solla P, Zara P, Sechi E. Myelitis features and outcomes in CNS demyelinating disorders:comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD[J]. Front Neurol, 2022, 13:1011579. [16] Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hümmert MW, Ringelstein M, Rommer PS, Ayzenberg I, Ruprecht K, Klotz L, Asgari N, Zrzavy T, Höftberger R, Tobia R, Buttmann M, Fechner K, Schanda K, Weber M, Asseyer S, Haas J, Lechner C, Kleiter I, Aktas O, Trebst C, Rostasy K, Reindl M, Kümpfel T, Paul F, Wildemann B; In Cooperation with the Neuromyelitis Optica Study Group (NEMOS). Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1:results from 163 lumbar punctures in 100 adult patients[J]. J Neuroinflammation, 2020, 17:261. [17] Huang JH, Li HL, Huang WY, Xu HM, Shan FL, Shu YQ, Qiu W, Long YM. Current research in autoimmune glial fibrillary acidic protein astrocytopathy[J]. Zhongguo Shen Jing Mian Yi Xue He Shen Jing Bing Xue Za Zhi, 2019, 26:437-440.[黄洁鸿,李惠璐,黄文瑶,徐辉明,单福兰,舒崖清,邱伟,龙友明.自身免疫性胶质纤维酸性蛋白星形细胞病的研究现状[J].中国神经免疫学和神经病学杂志, 2019, 26:437-440.] [18] Jarius S, Lechner C, Wendel EM, Baumann M, Breu M, Schimmel M, Karenfort M, Marina AD, Merkenschlager A, Thiels C, Blaschek A, Salandin M, Leiz S, Leypoldt F, Pschibul A, Hackenberg A, Hahn A, Syrbe S, Strautmanis J, Häusler M, Krieg P, Eisenkölbl A, Stoffels J, Eckenweiler M, Ayzenberg I, Haas J, Höftberger R, Kleiter I, Korporal-Kuhnke M, Ringelstein M, Ruprecht K, Siebert N, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, Rostásy K; In Cooperation with the BIOMARKER Study Group and the Neuromyelitis Optica Study Group (NEMOS). Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2:results from 108 lumbar punctures in 80 pediatric patients[J]. J Neuroinflammation, 2020, 17:262. P, Li H, [19] Yang X, Zhang C, Zhang J, Chen G, Zhao L, Yang Long Y. Autoimmune glial fibrillary acidic protein astrocytopathy mimics infectious meningitis:two case reports[J]. Mult Scler Relat Disord, 2020, 45:102350. suspected [20] Klion AD. Approach to the patient with hypereosinophilic syndrome[J]. Hematology Am Soc Hematol Educ Program, 2022, 2022:47-54. [21] Kanda A, Yasutaka Y, Van Bui D, Suzuki K, Sawada S, Kobayashi Y, Asako M, Iwai H. Multiple biological aspects of eosinophils in host defense, eosinophil-associated diseases, immunoregulation, and homeostasis:is their role beneficial, detrimental, regulator, or bystander[J]?Biol Pharm Bull, 2020, 43:20-30. [22] Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica:results from 211 lumbar punctures[J]. J Neurol Sci, 2011, 306(1/2):82-90. [23] Xiao J, Zhang SQ, Chen X, Tang Y, Chen M, Shang K, Deng G, Qin C, Tian DS. Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG+NMOSD mimicking intracranial infection as the initial manifestation[J]. Mult Scler Relat Disord, 2022, 66:104057. [24] Liang Y, Wang G, Li B, Li G, Zeng H. Autoimmune glial fibrillary acidic protein astrocytosis mimicking tuberculous meningitis:a retrospective study[J]. J Neurol, 2023, 270:4860-4867. [25] Long Y, Liang J, Xu H, Huang Q, Yang J, Gao C, Qiu W, Lin S, Chen X. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients:a retrospective study[J]. Eur J Neurol, 2018, 25:477-483. [26] Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T. The pathology of an autoimmune astrocytopathy:lessons learned from neuromyelitis optica[J]. Brain Pathol, 2014, 24:83-97. [27] Fang H, Hu W, Jiang Z, Yang H, Liao H, Yang L, Wu L. Autoimmune glial fibrillary acidic protein astrocytopathy in children:a retrospective analysis of 35 cases[J]. Front Immunol, 2021, 12:761354. [28] Zhu B, Sun M, Yang T, Yu H, Wang L. Clinical, imaging features and outcomes of patients with anti-GFAP antibodies:a retrospective study[J]. Front Immunol, 2023, 14:1106490. [29] Hasbun R. Progress and challenges in bacterial meningitis:a review[J]. JAMA, 2022, 328:2147-2154. [30] Zou Y, He J, Guo L, Bu H, Liu Y. Prediction of cerebrospinal fluid parameters for tuberculous meningitis[J]. Diagn Cytopathol, 2015, 43:701-704. [31] Hou C, Chen WX, Liao YT, Wu WX, Tian Y, Zhu HX, Peng BW, Zeng YR, Wu WL, Chen ZZ, Li XJ. Clinical analysis of autoimmune glial fibrillary acidic protein astrocytopathy in children[J]. Lin Chuang Er Ke Za Zhi, 2023, 41:656-660.[侯池,陈文雄,廖寅婷,吴文晓,田杨,朱海霞,彭炳蔚,曾意茹,吴汶霖,陈宗宗,李小晶.儿童自身免疫性胶质纤维酸性蛋白星形胶质细胞病临床分析[J].临床儿科杂志, 2023, 41:656-660.] [32] Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy[J]. Curr Opin Neurol, 2019, 32:452-458. [33] Tian DC, Li Z, Yuan M, Zhang C, Gu H, Wang Y, Shi FD. Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China:a national population-based study[J]. Lancet Reg Health West Pac, 2020, 2:100021. [34] Yang X, Liang J, Huang Q, Xu H, Gao C, Long Y, Xiao X. Treatment of autoimmune glial fibrillary acidic protein astrocytopathy:follow-up in 7 cases[J]. Neuroimmunomodulation, 2017, 24:113-119. |